Comparison
46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690 vs Abdominal Cystic Lymphangioma C2930929
Clinical comparison between 46 XY Disorder OF Sexual Development Due TO Dihydrotestosterone Backdoor Pathway Biosynthesis Defect and Abdominal Cystic Lymphangioma for differential diagnosis and treatment planning.
46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690
A rare enzyme defect affecting an alternative pathway for making dihydrotestosterone, a hormone important for male genital development. This can cause undervirilization. Treatment may include hormone therapy.
Abdominal Cystic Lymphangioma C2930929
A non-cancerous fluid-filled growth developing from lymphatic vessels in the abdomen. Usually found in children. Treatment may involve surgical removal or other interventions.
6 comparison axes
Onset
46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690
0-0
Abdominal Cystic Lymphangioma C2930929
0-null
Onset patterns differ
Severity
46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690
severe
Abdominal Cystic Lymphangioma C2930929
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690
Chronic
Abdominal Cystic Lymphangioma C2930929
Chronic
Differing course
Communicable
46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690
No
Abdominal Cystic Lymphangioma C2930929
No
Different transmission
Body System
46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690
reproductive
Abdominal Cystic Lymphangioma C2930929
congenital
Same/different system
Category
46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690
endocrine
Abdominal Cystic Lymphangioma C2930929
rare-disease
Different category
Bottom line
46-xy-disorder-of-sexual-development-due-to-dihydrotestosterone-backdoor-pathway-biosynthesis-defect-C5816690 and abdominal-cystic-lymphangioma-C2930929 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690 | Abdominal Cystic Lymphangioma C2930929 | Discriminating power |
|---|---|---|---|
| Genital development | May cause undervirilization in a 46,XY person. | Not described as affecting genital development. | High |
| Abdominal mass | No abdominal cystic growth is described. | May appear as a fluid-filled abdominal lymphatic growth. | High |
| Contagion | Not communicable. | Not communicable. | Low |
When to favor each condition
Choose 46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690 when
Atypical genital development in a 46,XY infant
The source links this rare enzyme defect to undervirilization.
Moderate
Suspected androgen biosynthesis disorder
Endocrine pathway evaluation is more relevant than abdominal-mass assessment.
Moderate
Need for long-term hormone-related care
Hormone therapy may be considered, but indications are not established here.
Low
Choose Abdominal Cystic Lymphangioma C2930929 when
Child with an abdominal cystic lesion
The source describes a benign lymphatic growth usually found in children.
Moderate
Imaging suggests a fluid-filled abdominal mass
This supports a cystic lesion rather than a hormone-pathway disorder.
Moderate
Local treatment is being considered
Surgical removal or other interventions may be used.
Moderate
How key tests differ
| Test | 46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690 | Abdominal Cystic Lymphangioma C2930929 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XY is part of the named condition. | No characteristic karyotype is supplied. | Karyotype alone does not establish the enzyme defect. |
| Hormone pathway testing | Specialist testing may be considered; no cutoff is supplied. | Not a primary test for this lesion. | Abnormal results require clinician interpretation and are not a diagnosis alone. |
| Abdominal imaging | No defining imaging finding is described. | May show a cystic abdominal lymphatic lesion. | Imaging can suggest the lesion but may need specialist confirmation. |
Prognosis comparison
46 Xy Disorder Of Sexual Development Due To Dihydrotestosterone Backdoor Pathway Biosynthesis Defect C5816690
- Outcome
- A severe chronic reproductive-endocrine condition is described, but individual outcome is not established.
- Factors
- Degree of undervirilization and response to specialist care may matter.
Abdominal Cystic Lymphangioma C2930929
- Outcome
- A moderate chronic benign lesion is described; outcome depends on clinical management.
- Factors
- Lesion effects and response to removal or other intervention may matter.
Time frame: From birth or childhood, with possible longer-term follow-up; exact duration is not established.
Diagnosis, complications, and treatment decisions require clinician interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Primary clinical consequence | Undervirilization may occur. A benign abdominal cystic growth may occur. These consequences involve different body systems. |
| Treatment-related burden | Hormone therapy may be considered. Surgery or another local intervention may be considered. Specific indications, doses, and outcomes are not established here. |
| Malignancy concern | No cancer risk is supplied. Described as noncancerous. Absence of supplied risk data does not exclude individual clinical concerns. |
Patient education highlights
- HighDifferent conditions
One is a rare hormone-development disorder; the other is a benign abdominal lymphatic cyst.
- MediumSpecialist care
Endocrine, genetics, pediatric, surgical, or radiology specialists may be needed as appropriate.
- LowUncertain details
Prevalence, exact test cutoffs, mortality, and treatment doses are not established by this source.